INO Inovio Pharmaceuticals Inc
Company Analysis
Latest News
🟢 Inovio Pharmaceuticals is trading 6.2% up today with the cause still unclear
Inovio Pharmaceuticals is trading 6.2% higher at $0.85 on October 22, 2026, with no clear cause identified. - No new company-specific announcement or clear...
🔴 Inovio Pharmaceuticals is trading 13% down with no confirmed catalyst identified
Inovio Pharmaceuticals is trading at $0.88, down 12.88%, with no confirmed company-specific catalyst identified for the October 21 decline. - The broad market...
🔴 Inovio Pharmaceuticals is trading 5.5% down with no confirmed catalyst
Inovio Pharmaceuticals is trading 5.48% lower at $0.95 on October 21, 2026; no specific catalyst for the decline is confirmed. - On October 20, the company...
🟢 Inovio Pharmaceuticals is trading 5.9% up in pre-market after announcing an $80.4 million judgment
Inovio Pharmaceuticals is trading at $1.07 (+5.94%) in pre-market, with its $80,416,101 judgment announcement a possible catalyst. - On October 20, the company...
🟢 Inovio Pharmaceuticals is trading 11% up in after-hours trading amid reported hantavirus-related vaccine-stock rally
Inovio Pharmaceuticals is trading 10.94% higher at $1.12 in after-hours trading; a report grouped it with vaccine stocks jumping amid hantavirus-related news,...
🟢 Inovio Pharmaceuticals is trading 10% up in after-hours trading
Inovio Pharmaceuticals is trading 9.87% higher at $1.11 after hours, following a regular-session close of $1.01; no clear company-specific announcement...
🟢 Inovio Pharmaceuticals is trading 6% up in after-hours trading; no verified company-specific catalyst reported
Inovio Pharmaceuticals is trading at $1.05, up 6.05% after hours; available reporting has not identified a verified company-specific catalyst. - An October 16...
🟢 Inovio Pharmaceuticals is trading 6.7% up in pre-market with no clear catalyst identified
Inovio Pharmaceuticals is trading at $1.11, up 6.7% in pre-market, with no clear company-specific catalyst identified for the October 16 rise. - Recent news...
🟢 Inovio Pharmaceuticals is trading 6% up — no clear catalyst identified
Inovio Pharmaceuticals is trading 5.98% higher at $1.04, with no clear company-specific catalyst identified. - The broader biotech sector is higher, with XBI...
🔴 Inovio Pharmaceuticals is trading 5% down — no clear catalyst identified
Inovio Pharmaceuticals is trading 5.22% down at $1.09, with no clear catalyst identified for the October 12 decline. - The FDA’s October 30 decision date for...
🟢 Inovio Pharmaceuticals is trading 6% up in pre-market with no clear catalyst identified
Inovio Pharmaceuticals is trading at $1.16, up 5.98%, with no clear company-specific catalyst identified in available October 9, 2026 news. - The latest...
🔴 Inovio Pharmaceuticals is trading 6.5% down today amid biotech-sector weakness
Inovio Pharmaceuticals is trading 6.49% down at $1.08, alongside weakness across the biotech sector. - XBI fell about 2% in the session, offering context but...
🟢 Inovio Pharmaceuticals is trading 5% up
Inovio Pharmaceuticals is trading at $1.19, up 5.31%, with no clear company-specific announcement explaining the move on October 7, 2026. - Recent coverage...
🟢 Inovio Pharmaceuticals is trading 10.4% up today amid broader-market gains after cooler inflation
Inovio Pharmaceuticals is trading at $1.23, up 10.36%, with broader-market strength after cooler-than-expected inflation the most likely backdrop. - August...
🟢 Inovio Pharmaceuticals is trading 5.4% up today amid cooler inflation and lower Treasury yields
Inovio Pharmaceuticals is trading at $1.17, up 5.39%, alongside broader-market strength attributed to cooler-than-expected inflation data and lower Treasury...
🔴 Inovio Pharmaceuticals is trading 5% down
Inovio Pharmaceuticals is trading at $1.11, down 5.13%, with no supported explanation for the decline in the available information. - No September 29 company...
🔴 Inovio Pharmaceuticals is trading 5.6% down today as biotech stocks weakened broadly
Inovio Pharmaceuticals is trading 5.6% down at $1.18, primarily as biotech stocks weakened broadly during the September 24, 2026 session. - XBI fell 2.04%,...
🟢 Inovio Pharmaceuticals rises 5.4% — Biotech Sector Surges in Pre-Market on Multiple Positive News Snippets
With Biotech (XBI) up 2.6%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 Inovio Pharmaceuticals is trading 5.73% up today; reason remains unconfirmed
Inovio Pharmaceuticals is trading 5.73% up at $1.31; the reason remains unconfirmed. - No clearly dated September 22, 2026 company-specific announcement or...
🟢 Inovio Pharmaceuticals is trading 5.7% up today as biotech stocks and broader U.S. markets rebound
Inovio Pharmaceuticals is trading 5.65% up now at $1.21 as biotechnology stocks and broader U.S. markets rebound on September 17, 2026. - No new...